Pionus

PAIRE
PAIRE is a software as a medical device for PET-CT examination with FDG, highlighting lesions on the PET scan. It receives DICOM images from the PET-CT modality and computes new images. Then, it returns them into the physician viewer as new images for the same study. It is fully integrated, vendor neutral, available in less than 5 minutes and requires no action from the radiologist. Its aim is to save time and improve the diagnosis with new information.
Information source: Vendor
Last updated: Nov. 8, 2022

General Information

General
Product name Pionus
Company PAIRE
Subspeciality All indications covered by FDG PET-CT
Modality CT, PET
Disease targeted All diseases diagnosed through FDG PET-CT
Key-features PET lesions detection, quantification, and segmentation
Suggested use Before: flagging acute findings
During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
After: diagnosis verification

Technical Specifications

Data characteristics
Population Adults above 18 years old
Input PET, CT, 3D, whole-body
Input format DICOM
Output Maximum Intensity Projection (MIP), series of key-images, overlay with lesions highlighted, table of quantifies values
Output format DICOM Secondary Capture
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA No or not yet
Intended Use Statements
Intended use (according to CE) Software as medical device that aims to assist nuclear medicine physicians to detect abnormalities on a 18F Fluorodeoxy-glucose (18F-FDG) positron emission tomography (PET) computed tomography (CT) medical images.

Market

Market presence
On market since 05-2021
Distribution channels Incepto, deepc OS
Countries present (clinical, non-research use) 1
Paying clinical customers (institutes) 6
Research/test users (institutes) 3
Pricing
Pricing model Subscription
Based on Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers